Cardinal

Cardinal Health and Shine Technologies Boost U.S. Radiopharmaceutical Production

U.S. Pushes for Radiopharmaceutical Independence as Demand Surges As global demand for radiopharmaceuticals and nuclear medicine continues to accelerate, U.S.-based manufacturers are stepping up efforts to expand domestic production capacity and reduce reliance on foreign supply chains. Radiopharmaceuticals—radioactive compounds used…

Read MoreCardinal Health and Shine Technologies Boost U.S. Radiopharmaceutical Production
Travere

Travere Therapeutics Reports First Quarter 2026 Financial Results

Travere Therapeutics Announces Q1 2026 Financial Results Travere Therapeutics, Inc. reported a strong start to 2026, marked by significant commercial growth, regulatory milestones, and continued advancement across its pipeline programs. The company’s first-quarter performance reflects increasing demand for its lead…

Read MoreTravere Therapeutics Reports First Quarter 2026 Financial Results
Evolus

Evolus Reports Q1 2026 Results; Posts Second Straight Positive Adjusted EBITDA and Reaffirms Outlook

Revenue grows 7% year over year to $73.1 million as the company advances toward full-year profitability and sustained double-digit growth Evolus, reported strong financial and operational performance for the first quarter of 2026, marking a notable continuation of its profitability…

Read MoreEvolus Reports Q1 2026 Results; Posts Second Straight Positive Adjusted EBITDA and Reaffirms Outlook
Anthem

Anthem Blue Cross and Blue Shield Helps Georgia Small Businesses Cut Costs and Improve Health

Anthem Blue Cross and Blue Shield Supports Georgia Small Businesses in Reducing Costs and Enhancing Health Outcomes As healthcare costs continue to climb across the United States, small businesses in Georgia are facing increasing pressure to provide quality employee benefits…

Read MoreAnthem Blue Cross and Blue Shield Helps Georgia Small Businesses Cut Costs and Improve Health